2021
DOI: 10.3390/pharmaceutics13101635
|View full text |Cite
|
Sign up to set email alerts
|

The Tragedy of Alzheimer’s Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes

Abstract: Alzheimer’s disease (AD) is a neurodegenerative disease where oxidative stress plays a major role as a key pathologic factor. The study aims to develop resveratrol (RES)-loaded bilosomes for oral use, aiming to enhance RES bioavailability. RES-loaded bilosomes were prepared using the thin-film hydration technique. The effect of different formulation variables viz. the number of extrusion cycles, drug concentration and the effect of pH of the medium and cholesterol addition on the physicochemical properties of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 40 publications
0
15
0
Order By: Relevance
“…Six non-overlapping high-power fields were randomly selected and scanned from each sample's DG areas to determine the area-based percentage of Ki-67 immune-expression levels in the immunohistochemically stained sections [75]. All light microscopic examinations and data collection were performed using the Leica Application module for histological analysis coupled to a full HD microscopic imaging system (Leica Microsystems GmbH, Wetzlar, Germany).…”
Section: Histology and Immunohistochemistrymentioning
confidence: 99%
“…Six non-overlapping high-power fields were randomly selected and scanned from each sample's DG areas to determine the area-based percentage of Ki-67 immune-expression levels in the immunohistochemically stained sections [75]. All light microscopic examinations and data collection were performed using the Leica Application module for histological analysis coupled to a full HD microscopic imaging system (Leica Microsystems GmbH, Wetzlar, Germany).…”
Section: Histology and Immunohistochemistrymentioning
confidence: 99%
“…Followed by incubation with anti Bcl2: PA5–11379 (Thermo Fisher Scientific Co.) Anti-Glial Fibrillary Acidic Protein (GFAP), by using a monoclonal antibody kit (Cat. No.13–0300-Thermo-scientific Co. Waltham, MA, USA) 1:100 overnight at 4C; washing followed by incubation with secondary antibody HRP Envision kit (DAKO) 20 mins; washing by PBS (phosphate buffer saline) and incubated with 3,3 diaminobenzidine (DAB) for 10 mins, then cover slipped for microscopic examination [ 42 ].…”
Section: Methodsmentioning
confidence: 99%
“…Six non-overlapping fields were randomly scanned per tissue section of each sample for the determination of the relative area percentage of immunohistochemical expression levels of Bcl2 and GFAP in the cerebral cortex of different groups. Morphological measurements and analyzed data were obtained using Leica Application module for tissue section analysis attached to a Full HD microscopic imaging system (Leica Microsystems GmbH, Germany) [ 42 ].…”
Section: Methodsmentioning
confidence: 99%
“…Another set of tissue sections was stained by Toluidine blue stain for the quantification of intact neurons, then inspected with light microscope. Standard protocols for sample preparation, staining, and analysis were followed according to Abbas, Culling and Abbas [ 81 , 82 , 83 ].…”
Section: Methodsmentioning
confidence: 99%